GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹1.66 Cr | ₹1.30 Cr | ₹1.02 Cr | ₹0.98 Cr | ₹0.86 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of GUJARAT THEMIS BIOSYN ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹1.66 Cr |
Mar2023 | ₹1.30 Cr |
Mar2022 | ₹1.02 Cr |
Mar2021 | ₹0.98 Cr |
Mar2020 | ₹0.86 Cr |
How is Deferred Tax Assets / Liabilities of GUJARAT THEMIS BIOSYN Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1.66 Cr | 28.00 | |
Mar2023 | ₹1.30 Cr | 26.95 | |
Mar2022 | ₹1.02 Cr | 4.60 | |
Mar2021 | ₹0.98 Cr | 13.31 | |
Mar2020 | ₹0.86 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of GUJARAT THEMIS BIOSYN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUJARAT THEMIS BIOSYN | ₹2,839.5 Cr | -9.7% | -19.3% | 19.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,044.0 Cr | -0.2% | -1% | 9.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,537.0 Cr | -2.1% | 1.5% | 61.3% | Stock Analytics | |
CIPLA | ₹118,889.0 Cr | -0% | 2% | -0.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,075.0 Cr | -1.4% | -6.1% | -4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,832.5 Cr | -5.2% | -4.7% | 8.9% | Stock Analytics |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUJARAT THEMIS BIOSYN | -9.7% |
-19.3% |
19.9% |
SENSEX | -2.5% |
-0.8% |
7.1% |
You may also like the below Video Courses